Literature DB >> 17045707

Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties.

Irini A Doytchinova1, Darren R Flower.   

Abstract

Subunit vaccine discovery is an accepted clinical priority. The empirical approach is time- and labor-consuming and can often end in failure. Rational information-driven approaches can overcome these limitations in a fast and efficient manner. However, informatics solutions require reliable algorithms for antigen identification. All known algorithms use sequence similarity to identify antigens. However, antigenicity may be encoded subtly in a sequence and may not be directly identifiable by sequence alignment. We propose a new alignment-independent method for antigen recognition based on the principal chemical properties of protein amino acid sequences. The method is tested by cross-validation on a training set of bacterial antigens and external validation on a test set of known antigens. The prediction accuracy is 83% for the cross-validation and 80% for the external test set. Our approach is accurate and robust, and provides a potent tool for the in silico discovery of medically relevant subunit vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045707     DOI: 10.1016/j.vaccine.2006.09.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  45 in total

1.  High-throughput prediction of protein antigenicity using protein microarray data.

Authors:  Christophe N Magnan; Michael Zeller; Matthew A Kayala; Adam Vigil; Arlo Randall; Philip L Felgner; Pierre Baldi
Journal:  Bioinformatics       Date:  2010-10-07       Impact factor: 6.937

2.  Mature Epitope Density--a strategy for target selection based on immunoinformatics and exported prokaryotic proteins.

Authors:  Anderson R Santos; Vanessa Bastos Pereira; Eudes Barbosa; Jan Baumbach; Josch Pauling; Richard Röttger; Meritxell Zurita Turk; Artur Silva; Anderson Miyoshi; Vasco Azevedo
Journal:  BMC Genomics       Date:  2013-10-25       Impact factor: 3.969

3.  Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development.

Authors:  Muna F Abry; Kelvin M Kimenyi; Fred O Osowo; Willingtone O Odhiambo; Steven O Sewe; Benard W Kulohoma
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Computer aided selection of candidate vaccine antigens.

Authors:  Darren R Flower; Isabel K Macdonald; Kamna Ramakrishnan; Matthew N Davies; Irini A Doytchinova
Journal:  Immunome Res       Date:  2010-11-03

5.  In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein.

Authors:  Mandana Behbahani; Mohammad Moradi; Hassan Mohabatkar
Journal:  In Silico Pharmacol       Date:  2021-05-11

6.  Discriminating antigen and non-antigen using proteome dissimilarity III: tumour and parasite antigens.

Authors:  Kamna Ramakrishnan; Darren R Flower
Journal:  Bioinformation       Date:  2010-06-24

7.  Discriminating antigen and non-antigen using proteome dissimilarity II: viral and fungal antigens.

Authors:  Kamna Ramakrishnan; Darren R Flower
Journal:  Bioinformation       Date:  2010-06-24

8.  AntigenDB: an immunoinformatics database of pathogen antigens.

Authors:  Hifzur Rahman Ansari; Darren R Flower; G P S Raghava
Journal:  Nucleic Acids Res       Date:  2009-10-09       Impact factor: 16.971

9.  Combination of highly antigenic nucleoproteins to inaugurate a cross-reactive next generation vaccine candidate against Arenaviridae family.

Authors:  Kazi Faizul Azim; Tahera Lasker; Rahima Akter; Mantasha Mahmud Hia; Omar Faruk Bhuiyan; Mahmudul Hasan; Md Nazmul Hossain
Journal:  Heliyon       Date:  2021-05-19

10.  Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches.

Authors:  Samira Sanami; Fatemeh Azadegan-Dehkordi; Mahmoud Rafieian-Kopaei; Majid Salehi; Maryam Ghasemi-Dehnoo; Mehran Mahooti; Morteza Alizadeh; Nader Bagheri
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.